These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9266357)

  • 1. Complete reversal of moderate/severe brain MRI abnormalities in a patient with classical phenylketonuria.
    Walter JH; White F; Wraith JE; Jenkins JP; Wilson BP
    J Inherit Metab Dis; 1997 Jul; 20(3):367-9. PubMed ID: 9266357
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnetic resonance imaging of the brain in phenylketonuria.
    Cleary MA; Walter JH; Wraith JE; Jenkins JP; Alani SM; Tyler K; Whittle D
    Lancet; 1994 Jul; 344(8915):87-90. PubMed ID: 7912392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change.
    Cleary MA; Walter JH; Wraith JE; White F; Tyler K; Jenkins JP
    J Pediatr; 1995 Aug; 127(2):251-5. PubMed ID: 7636650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Magnetic resonance imaging of the brain in phenylketonuria].
    Izumi M; Yamazaki H; Nakabayashi H; Owada M
    No To Hattatsu; 2006 Jan; 38(1):27-31. PubMed ID: 16447793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of cerebral white matter abnormalities in early treated patients with phenylketonuria during adolescence.
    Weglage J; Bick U; Schuierer G; Pietsch M; Sprinz A; Zass R; Ullrich K
    Neuropediatrics; 1997 Aug; 28(4):239-40. PubMed ID: 9309716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging changes in early treated patients with phenylketonuria.
    Thompson AJ; Smith I; Kendall BE; Youl BD; Brenton D
    Lancet; 1991 May; 337(8751):1224. PubMed ID: 1673760
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenylketonuria, an unusual diagnosis of mental retardation in an adult patient.
    Papassin J; Pierunek J; Corne C; Besson G
    Rev Neurol (Paris); 2015 Oct; 171(10):739-40. PubMed ID: 26184060
    [No Abstract]   [Full Text] [Related]  

  • 8. Malignant hyperphenylalaninemia: CT and MR of the brain.
    Brismar J; Aqeel A; Gascon G; Ozand P
    AJNR Am J Neuroradiol; 1990; 11(1):135-8. PubMed ID: 2105595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No white matter abnormalities in untreated patients with persistent hyperphenylalaninaemia: findings in magnetic resonance imaging. German PKU Collaborative Study.
    Weglage J; Ullrich K; Schuierer G; Pietsch M; Fünders B
    Eur J Pediatr; 1994 Dec; 153(12):918-9. PubMed ID: 7859796
    [No Abstract]   [Full Text] [Related]  

  • 10. Adult phenylketonuria presenting with subacute severe neurologic symptoms.
    Seki M; Takizawa T; Suzuki S; Shimizu T; Shibata H; Ishii T; Hasegawa T; Suzuki N
    J Clin Neurosci; 2015 Aug; 22(8):1361-3. PubMed ID: 25913748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological deterioration in adult phenylketonuria.
    Villasana D; Butler IJ; Williams JC; Roongta SM
    J Inherit Metab Dis; 1989; 12(4):451-7. PubMed ID: 2516176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging of phenylketonuria.
    Shaw DW; Maravilla KR; Weinberger E; Garretson J; Trahms CM; Scott CR
    AJNR Am J Neuroradiol; 1991; 12(3):403-6. PubMed ID: 2058482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cranial MR in phenylketonuria.
    Shaw DW; Weinberger E; Maravilla KR
    J Comput Assist Tomogr; 1990; 14(3):458-60. PubMed ID: 2335616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain CT and MR findings in hyperphenylalaninemia due to dihydropteridine reductase deficiency (variant of phenylketonuria).
    Sugita R; Takahashi S; Ishii K; Matsumoto K; Ishibashi T; Sakamoto K; Narisawa K
    J Comput Assist Tomogr; 1990; 14(5):699-703. PubMed ID: 2398144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected white matter changes in an early treated PKU case and improvement after dietary treatment.
    Battistini S; De Stefano N; Parlanti S; Federico A
    Funct Neurol; 1991; 6(2):177-80. PubMed ID: 1916459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Man made disease: clinical manifestations of low phenylalanine levels in an inadequately treated phenylketonuria patient and mouse study.
    Pode-Shakked B; Shemer-Meiri L; Harmelin A; Stettner N; Brenner O; Abraham S; Schwartz G; Anikster Y
    Mol Genet Metab; 2013; 110 Suppl():S66-70. PubMed ID: 24206931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric disorders in adult patients with early-treated phenylketonuria.
    Pietz J; Fätkenheuer B; Burgard P; Armbruster M; Esser G; Schmidt H
    Pediatrics; 1997 Mar; 99(3):345-50. PubMed ID: 9041285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological and neuroradiological (MRI) variations during phenylalanine load: protective effect of valine, leucine, and isoleucine supplementation.
    Leuzzi V; Fois D; Carducci C; Antonozzi I; Trasimeni G
    J Child Neurol; 1997 Aug; 12(5):338-40. PubMed ID: 9378904
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurological deterioration in young adults with phenylketonuria.
    Thompson AJ; Smith I; Brenton D; Youl BD; Rylance G; Davidson DC; Kendall B; Lees AJ
    Lancet; 1990 Sep; 336(8715):602-5. PubMed ID: 1975386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical control, genetic analysis and magnetic resonance imaging in patients with phenylketonuria.
    Walter JH; Tyfield LA; Holton JB; Johnson C
    Eur J Pediatr; 1993 Oct; 152(10):822-7. PubMed ID: 7901023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.